Matches in SemOpenAlex for { <https://semopenalex.org/work/W4316813126> ?p ?o ?g. }
- W4316813126 abstract "The antiphagocytic molecule CD47 is overexpressed in a wide variety of cancer cells, and antibodies targeting CD47 for cancer therapies are currently under intensive investigation. However, owing to the ubiquitous expression of CD47 on healthy cells, anti-CD47 therapies often achieve only weak therapeutic benefits and can induce severe side effects. Here, we report the generation of a pH-dependent anti-CD47 antibody (BC31M4) which selectively binds to tumors under the acidic solid tumor microenvironment.BC31M4 was generated using antibody phage display and a pH-dependent selection strategy. The pH-dependent binding and blocking activities of BC31M4 were verified using in vitro assays, and the structural basis of the pH-dependent binding property was characterized. BC31M4's antitumor effect was confirmed by both phagocytosis assays and studies in xenograft models. The tumor selectivity, mechanism of action, PK properties, side effects, and therapeutic efficacy were further evaluated in humanized (hCD47 and its receptor hSIRPα) immunocompetent syngeneic mouse models.The crystal structure reveals that two histidines locate within the CDRs of the light chain directly contribute to the pH-dependent binding of BC31M4. BC31M4 promotes macrophage phagocytosis of tumor cells more potently at acidic-pH than at physiological-pH. Our hCD47/hSIRPα humanized syngeneic mouse model results demonstrated that BC31M4 selectively accumulates in tumors but not in normal tissues. BC31M4 causes minimal side effects and exhibits superior PK properties as compared to the other examined anti-CD47 antibodies. When combined with adoptive T cell transfer, BC31M4 efficiently promotes adaptive immune responses against tumors and also induces immune memory. Moreover, we show that BC31M4's antitumor effects rely on an Fc that mediates strong effector functions.Our study illustrates that the development of a tumor-selective, pH-dependent anti-CD47 antibody safely confers strong therapeutic effects against solid tumors, thus providing a promising therapeutic strategy to overcome the challenges of anti-CD47 therapy." @default.
- W4316813126 created "2023-01-17" @default.
- W4316813126 creator A5003254821 @default.
- W4316813126 creator A5011603239 @default.
- W4316813126 creator A5012738713 @default.
- W4316813126 creator A5017541508 @default.
- W4316813126 creator A5037332709 @default.
- W4316813126 creator A5045054087 @default.
- W4316813126 creator A5046597133 @default.
- W4316813126 creator A5048234507 @default.
- W4316813126 creator A5051527271 @default.
- W4316813126 creator A5054886077 @default.
- W4316813126 creator A5062637798 @default.
- W4316813126 creator A5063103450 @default.
- W4316813126 creator A5073119898 @default.
- W4316813126 creator A5080125836 @default.
- W4316813126 creator A5086866538 @default.
- W4316813126 creator A5089603004 @default.
- W4316813126 date "2023-01-17" @default.
- W4316813126 modified "2023-10-15" @default.
- W4316813126 title "A pH-dependent anti-CD47 antibody that selectively targets solid tumors and improves therapeutic efficacy and safety" @default.
- W4316813126 cites W1488083143 @default.
- W4316813126 cites W1540070913 @default.
- W4316813126 cites W1540592014 @default.
- W4316813126 cites W1568582447 @default.
- W4316813126 cites W1901785997 @default.
- W4316813126 cites W1948560807 @default.
- W4316813126 cites W1959677146 @default.
- W4316813126 cites W1966217032 @default.
- W4316813126 cites W1983217073 @default.
- W4316813126 cites W2021865808 @default.
- W4316813126 cites W2033385652 @default.
- W4316813126 cites W2039949492 @default.
- W4316813126 cites W2042858467 @default.
- W4316813126 cites W2044062220 @default.
- W4316813126 cites W2057745345 @default.
- W4316813126 cites W2057796048 @default.
- W4316813126 cites W2059050919 @default.
- W4316813126 cites W2062826169 @default.
- W4316813126 cites W2068052762 @default.
- W4316813126 cites W2091130738 @default.
- W4316813126 cites W2097126393 @default.
- W4316813126 cites W2097259163 @default.
- W4316813126 cites W2103746815 @default.
- W4316813126 cites W2106545303 @default.
- W4316813126 cites W2124026197 @default.
- W4316813126 cites W2127438212 @default.
- W4316813126 cites W2130503287 @default.
- W4316813126 cites W2133346943 @default.
- W4316813126 cites W2139418176 @default.
- W4316813126 cites W2147874841 @default.
- W4316813126 cites W2154672378 @default.
- W4316813126 cites W2167795547 @default.
- W4316813126 cites W2180229411 @default.
- W4316813126 cites W2205886515 @default.
- W4316813126 cites W2339658610 @default.
- W4316813126 cites W2414840542 @default.
- W4316813126 cites W2550646651 @default.
- W4316813126 cites W2574981959 @default.
- W4316813126 cites W2590534615 @default.
- W4316813126 cites W2596636194 @default.
- W4316813126 cites W2597064996 @default.
- W4316813126 cites W2754702834 @default.
- W4316813126 cites W2782076004 @default.
- W4316813126 cites W2795318100 @default.
- W4316813126 cites W2797057269 @default.
- W4316813126 cites W2883266145 @default.
- W4316813126 cites W2888609501 @default.
- W4316813126 cites W2899044337 @default.
- W4316813126 cites W2907227169 @default.
- W4316813126 cites W2916884115 @default.
- W4316813126 cites W2964672224 @default.
- W4316813126 cites W2985006520 @default.
- W4316813126 cites W2989105549 @default.
- W4316813126 cites W2990699742 @default.
- W4316813126 cites W3105876484 @default.
- W4316813126 cites W3157188545 @default.
- W4316813126 cites W3171647440 @default.
- W4316813126 cites W4226400638 @default.
- W4316813126 cites W4280641209 @default.
- W4316813126 doi "https://doi.org/10.1186/s13045-023-01399-4" @default.
- W4316813126 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36650558" @default.
- W4316813126 hasPublicationYear "2023" @default.
- W4316813126 type Work @default.
- W4316813126 citedByCount "2" @default.
- W4316813126 countsByYear W43168131262023 @default.
- W4316813126 crossrefType "journal-article" @default.
- W4316813126 hasAuthorship W4316813126A5003254821 @default.
- W4316813126 hasAuthorship W4316813126A5011603239 @default.
- W4316813126 hasAuthorship W4316813126A5012738713 @default.
- W4316813126 hasAuthorship W4316813126A5017541508 @default.
- W4316813126 hasAuthorship W4316813126A5037332709 @default.
- W4316813126 hasAuthorship W4316813126A5045054087 @default.
- W4316813126 hasAuthorship W4316813126A5046597133 @default.
- W4316813126 hasAuthorship W4316813126A5048234507 @default.
- W4316813126 hasAuthorship W4316813126A5051527271 @default.
- W4316813126 hasAuthorship W4316813126A5054886077 @default.
- W4316813126 hasAuthorship W4316813126A5062637798 @default.
- W4316813126 hasAuthorship W4316813126A5063103450 @default.
- W4316813126 hasAuthorship W4316813126A5073119898 @default.